Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann Godet

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Cancers|January 11, 2022
Harnessing Antitumor CD4<sup>+</sup> T Cells for Cancer ImmunotherapyMyriam Ben Khelil, Yann Godet, Syrine Abdeljaoued, et al.
Folia Parasitologica|September 15, 2017
Echinococcus multilocularis vesicular fluid inhibits activation and proliferation of natural killer cellsAnne-Pauline Bellanger, Valentine Mougey, Jean-Rene Pallandre, et al.
Cancer Gene Therapy|October 14, 2021
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cellsChrystel Marton, Patricia Mercier-Letondal, Romain Loyon, et al.
European Journal of Immunology|March 11, 2010
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapyYann Godet, Juliette Desfrançois, Virginie Vignard, et al.
Cancer Immunology, Immunotherapy : CII|July 10, 2008
A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patientsYann Godet, Annabelle Bonnin, Yannik Guilloux, et al.
The Journal of Experimental Medicine|October 22, 2008
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiencyYann Godet, Agnès Moreau-Aubry, Yannik Guilloux, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2025
Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior <i>in vivo</i> T cell historyPatricia Mercier-Letondal, Chrystel Marton, Bernard Royer, et al.
Plos One|January 7, 2010
Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomasJuliette Desfrançois, Agnès Moreau-Aubry, Virginie Vignard, et al.
Journal of Immunological Methods|November 24, 2016
Fungal peptides from pneumonitis hypersensitivity etiologic agents are able to induce specific cellular immune responseAnne-Pauline Bellanger, Thibaud Lignon, Yann Godet, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2009
An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 contextYann Godet, Agnès Moreau-Aubry, Dimitri Mompelat, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Cancers|January 11, 2022
Harnessing Antitumor CD4<sup>+</sup> T Cells for Cancer ImmunotherapyMyriam Ben Khelil, Yann Godet, Syrine Abdeljaoued, et al.
Folia Parasitologica|September 15, 2017
Echinococcus multilocularis vesicular fluid inhibits activation and proliferation of natural killer cellsAnne-Pauline Bellanger, Valentine Mougey, Jean-Rene Pallandre, et al.
Cancer Gene Therapy|October 14, 2021
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cellsChrystel Marton, Patricia Mercier-Letondal, Romain Loyon, et al.
European Journal of Immunology|March 11, 2010
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapyYann Godet, Juliette Desfrançois, Virginie Vignard, et al.
Cancer Immunology, Immunotherapy : CII|July 10, 2008
A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patientsYann Godet, Annabelle Bonnin, Yannik Guilloux, et al.
The Journal of Experimental Medicine|October 22, 2008
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiencyYann Godet, Agnès Moreau-Aubry, Yannik Guilloux, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2025
Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior <i>in vivo</i> T cell historyPatricia Mercier-Letondal, Chrystel Marton, Bernard Royer, et al.
Plos One|January 7, 2010
Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomasJuliette Desfrançois, Agnès Moreau-Aubry, Virginie Vignard, et al.
Journal of Immunological Methods|November 24, 2016
Fungal peptides from pneumonitis hypersensitivity etiologic agents are able to induce specific cellular immune responseAnne-Pauline Bellanger, Thibaud Lignon, Yann Godet, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2009
An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 contextYann Godet, Agnès Moreau-Aubry, Dimitri Mompelat, et al.
Pageof 6